Estrogen metabolism and mammographic density in postmenopausal women

A cross-sectional study

Barbara J. Fuhrman, Louise A. Brinton, Ruth M. Pfeiffer, Xia Xu, Timothy D. Veenstra, Barbara E. Teter, Celia Byrne, Cher M. Dallal, Maddalena Barba, Paola C. Muti, Gretchen L. Gierach

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Prospective studies have consistently found that postmenopausal breast cancer risk increases with circulating estrogens; however, findings from studies of estrogens and mammographic density (MD), an intermediate marker of breast cancer risk, have been inconsistent. We investigated the cross-sectional associations of urinary estrogens, and their 2-, 4-, and 16-hydroxylated metabolites with MD. Methods: Postmenopausal women without breast cancer (n = 194), ages 48 to 82 years, and reporting no current menopausal hormone therapy use were enrolled at a clinic in Western NY in 2005. Urinary estrogens and estrogen metabolites were measured using mass spectrometry. Percent MD and dense area (cm2) were measured using computer-assisted analyses of digitized films. Linear regression models were used to estimate associations of log-transformed estrogen measures with MD while adjusting for age, body mass index (BMI), parity, and past hormone therapy use. Results: Urinary concentrations of most individual estrogens and metabolites were not associated with MD; however, across the interdecile range of the ratio of parent estrogens (estrone and estradiol) to their metabolites, MD increased by 6.8 percentage points (P = 0.02) and dense area increased by 10.3 cm2 (P = 0.03). Across the interdecile ranges of the ratios of 2-, 4-, and 16-hydroxylation pathways to the parent estrogens, MD declined by 6.2 (P = 0.03), 6.4 (P = 0.04), and 5.7 (P = 0.05) percentage points, respectively. All associations remained apparent in models without adjustment for BMI. Conclusion: In this study of postmenopausal women, less extensive hydroxylation of parent estrogens was associated with higher MD. Impact: Hydroxylation of estrogens may modulate postmenopausal breast cancer risk through a pathway involving MD.

Original languageEnglish
Pages (from-to)1582-1591
Number of pages10
JournalCancer Epidemiology Biomarkers and Prevention
Volume21
Issue number9
DOIs
Publication statusPublished - Sep 2012

Fingerprint

Estrogens
Cross-Sectional Studies
Hydroxylation
Breast Neoplasms
Linear Models
Body Mass Index
Breast Density
Hormones
Estrone
Parity
Estradiol
Mass Spectrometry
Prospective Studies
Therapeutics

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Fuhrman, B. J., Brinton, L. A., Pfeiffer, R. M., Xu, X., Veenstra, T. D., Teter, B. E., ... Gierach, G. L. (2012). Estrogen metabolism and mammographic density in postmenopausal women: A cross-sectional study. Cancer Epidemiology Biomarkers and Prevention, 21(9), 1582-1591. https://doi.org/10.1158/1055-9965.EPI-12-0247

Estrogen metabolism and mammographic density in postmenopausal women : A cross-sectional study. / Fuhrman, Barbara J.; Brinton, Louise A.; Pfeiffer, Ruth M.; Xu, Xia; Veenstra, Timothy D.; Teter, Barbara E.; Byrne, Celia; Dallal, Cher M.; Barba, Maddalena; Muti, Paola C.; Gierach, Gretchen L.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 21, No. 9, 09.2012, p. 1582-1591.

Research output: Contribution to journalArticle

Fuhrman, BJ, Brinton, LA, Pfeiffer, RM, Xu, X, Veenstra, TD, Teter, BE, Byrne, C, Dallal, CM, Barba, M, Muti, PC & Gierach, GL 2012, 'Estrogen metabolism and mammographic density in postmenopausal women: A cross-sectional study', Cancer Epidemiology Biomarkers and Prevention, vol. 21, no. 9, pp. 1582-1591. https://doi.org/10.1158/1055-9965.EPI-12-0247
Fuhrman, Barbara J. ; Brinton, Louise A. ; Pfeiffer, Ruth M. ; Xu, Xia ; Veenstra, Timothy D. ; Teter, Barbara E. ; Byrne, Celia ; Dallal, Cher M. ; Barba, Maddalena ; Muti, Paola C. ; Gierach, Gretchen L. / Estrogen metabolism and mammographic density in postmenopausal women : A cross-sectional study. In: Cancer Epidemiology Biomarkers and Prevention. 2012 ; Vol. 21, No. 9. pp. 1582-1591.
@article{7b1332b6b8ce426c97aaee2d4ea243e9,
title = "Estrogen metabolism and mammographic density in postmenopausal women: A cross-sectional study",
abstract = "Background: Prospective studies have consistently found that postmenopausal breast cancer risk increases with circulating estrogens; however, findings from studies of estrogens and mammographic density (MD), an intermediate marker of breast cancer risk, have been inconsistent. We investigated the cross-sectional associations of urinary estrogens, and their 2-, 4-, and 16-hydroxylated metabolites with MD. Methods: Postmenopausal women without breast cancer (n = 194), ages 48 to 82 years, and reporting no current menopausal hormone therapy use were enrolled at a clinic in Western NY in 2005. Urinary estrogens and estrogen metabolites were measured using mass spectrometry. Percent MD and dense area (cm2) were measured using computer-assisted analyses of digitized films. Linear regression models were used to estimate associations of log-transformed estrogen measures with MD while adjusting for age, body mass index (BMI), parity, and past hormone therapy use. Results: Urinary concentrations of most individual estrogens and metabolites were not associated with MD; however, across the interdecile range of the ratio of parent estrogens (estrone and estradiol) to their metabolites, MD increased by 6.8 percentage points (P = 0.02) and dense area increased by 10.3 cm2 (P = 0.03). Across the interdecile ranges of the ratios of 2-, 4-, and 16-hydroxylation pathways to the parent estrogens, MD declined by 6.2 (P = 0.03), 6.4 (P = 0.04), and 5.7 (P = 0.05) percentage points, respectively. All associations remained apparent in models without adjustment for BMI. Conclusion: In this study of postmenopausal women, less extensive hydroxylation of parent estrogens was associated with higher MD. Impact: Hydroxylation of estrogens may modulate postmenopausal breast cancer risk through a pathway involving MD.",
author = "Fuhrman, {Barbara J.} and Brinton, {Louise A.} and Pfeiffer, {Ruth M.} and Xia Xu and Veenstra, {Timothy D.} and Teter, {Barbara E.} and Celia Byrne and Dallal, {Cher M.} and Maddalena Barba and Muti, {Paola C.} and Gierach, {Gretchen L.}",
year = "2012",
month = "9",
doi = "10.1158/1055-9965.EPI-12-0247",
language = "English",
volume = "21",
pages = "1582--1591",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Estrogen metabolism and mammographic density in postmenopausal women

T2 - A cross-sectional study

AU - Fuhrman, Barbara J.

AU - Brinton, Louise A.

AU - Pfeiffer, Ruth M.

AU - Xu, Xia

AU - Veenstra, Timothy D.

AU - Teter, Barbara E.

AU - Byrne, Celia

AU - Dallal, Cher M.

AU - Barba, Maddalena

AU - Muti, Paola C.

AU - Gierach, Gretchen L.

PY - 2012/9

Y1 - 2012/9

N2 - Background: Prospective studies have consistently found that postmenopausal breast cancer risk increases with circulating estrogens; however, findings from studies of estrogens and mammographic density (MD), an intermediate marker of breast cancer risk, have been inconsistent. We investigated the cross-sectional associations of urinary estrogens, and their 2-, 4-, and 16-hydroxylated metabolites with MD. Methods: Postmenopausal women without breast cancer (n = 194), ages 48 to 82 years, and reporting no current menopausal hormone therapy use were enrolled at a clinic in Western NY in 2005. Urinary estrogens and estrogen metabolites were measured using mass spectrometry. Percent MD and dense area (cm2) were measured using computer-assisted analyses of digitized films. Linear regression models were used to estimate associations of log-transformed estrogen measures with MD while adjusting for age, body mass index (BMI), parity, and past hormone therapy use. Results: Urinary concentrations of most individual estrogens and metabolites were not associated with MD; however, across the interdecile range of the ratio of parent estrogens (estrone and estradiol) to their metabolites, MD increased by 6.8 percentage points (P = 0.02) and dense area increased by 10.3 cm2 (P = 0.03). Across the interdecile ranges of the ratios of 2-, 4-, and 16-hydroxylation pathways to the parent estrogens, MD declined by 6.2 (P = 0.03), 6.4 (P = 0.04), and 5.7 (P = 0.05) percentage points, respectively. All associations remained apparent in models without adjustment for BMI. Conclusion: In this study of postmenopausal women, less extensive hydroxylation of parent estrogens was associated with higher MD. Impact: Hydroxylation of estrogens may modulate postmenopausal breast cancer risk through a pathway involving MD.

AB - Background: Prospective studies have consistently found that postmenopausal breast cancer risk increases with circulating estrogens; however, findings from studies of estrogens and mammographic density (MD), an intermediate marker of breast cancer risk, have been inconsistent. We investigated the cross-sectional associations of urinary estrogens, and their 2-, 4-, and 16-hydroxylated metabolites with MD. Methods: Postmenopausal women without breast cancer (n = 194), ages 48 to 82 years, and reporting no current menopausal hormone therapy use were enrolled at a clinic in Western NY in 2005. Urinary estrogens and estrogen metabolites were measured using mass spectrometry. Percent MD and dense area (cm2) were measured using computer-assisted analyses of digitized films. Linear regression models were used to estimate associations of log-transformed estrogen measures with MD while adjusting for age, body mass index (BMI), parity, and past hormone therapy use. Results: Urinary concentrations of most individual estrogens and metabolites were not associated with MD; however, across the interdecile range of the ratio of parent estrogens (estrone and estradiol) to their metabolites, MD increased by 6.8 percentage points (P = 0.02) and dense area increased by 10.3 cm2 (P = 0.03). Across the interdecile ranges of the ratios of 2-, 4-, and 16-hydroxylation pathways to the parent estrogens, MD declined by 6.2 (P = 0.03), 6.4 (P = 0.04), and 5.7 (P = 0.05) percentage points, respectively. All associations remained apparent in models without adjustment for BMI. Conclusion: In this study of postmenopausal women, less extensive hydroxylation of parent estrogens was associated with higher MD. Impact: Hydroxylation of estrogens may modulate postmenopausal breast cancer risk through a pathway involving MD.

UR - http://www.scopus.com/inward/record.url?scp=84866143486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866143486&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-12-0247

DO - 10.1158/1055-9965.EPI-12-0247

M3 - Article

VL - 21

SP - 1582

EP - 1591

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 9

ER -